Statement: Broader Medicare Coverage of Leqembi Available Following FDA Traditional Approval
(Source – www.cms.gov/newsroom) Broader Medicare coverage is now available for Biogen and Eisai’s Leqembi (the brand name for lecanemab) following
Read More
CMS
Medicare Advantage star ratings are failing to improve plan quality: Study
(By Jakob Emerson for Becker’s Hospital Review) The Medicare Advantage star rating system and its quality bonus payment program is
Read MoreCMS Releases Revised Guidance for Historic Medicare Drug Price Negotiation Program
(Source – www.cms.gov/newsroom) For the first time in history, Medicare has the ability to directly negotiate the prices of covered
Read MoreThe 2-midnight rule and Medicare Advantage: 6 things to know
(By Jakob Emerson for Becker’s Hospital Review) There are major changes afoot for Medicare Advantage plans and when they are
Read MoreAn Alzheimer’s drug is on the way, but getting it may still be tough. Here’s why
(By Jon Hamilton for NPR) The first drug shown to slow down Alzheimer’s disease is likely to receive full approval
Read MoreTransforming Medicare Coverage: A New Medicare Coverage Pathway for Emerging Technologies and Revamped Evidence Development Framework
(Source – www.cms.gov) The Centers for Medicare & Medicaid Services (CMS) is committed to fostering innovation while ensuring that people
Read MoreLawmakers want CMS’ prior authorization proposal to go further
(By Andrew Cass for Becker’s Hospital Review) More than 230 U.S. representatives and 61 senators are asking HHS and CMS
Read MoreCMS: Private insurance spending to increase in 2023, 2024; slow in 2025 onward
(By Rylee Wilson for Becker’s Hospital Review) CMS is projecting a 7.7 percent increase in private health insurance spending in
Read MoreThe current Medicare Advantage payment structure results in overpayments
Current research states that the millions of beneficiaries in traditional Medicare who have switched to Medicare Advantage plans have lower
Read MoreInflation Reduction Act Continues to Lower Out-of-Pocket Prescription Drug Costs for Drugs with Price Increases Above Inflation
(Source – cms.gov/newsroom) A continuing key priority of the Biden-Harris Administration is lowering prescription drug costs. Today, the Department of
Read More